Yüklüyor......
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
BACKGROUND AND AIMS: It is unclear whether direct-acting antiviral (DAA) treatment-induced sustained virologic response (SVR) reduces the risk of hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV) infection. We aimed to determine the impact of DAA-induced SVR on HCC risk. METHOD...
Kaydedildi:
| Yayımlandı: | J Hepatol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5837901/ https://ncbi.nlm.nih.gov/pubmed/28887168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2017.08.030 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|